These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 3852897

  • 1. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Sato K, Lin TY, Weintrub L, Olsen K, McCracken GH.
    Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
    [Abstract] [Full Text] [Related]

  • 2. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T, Domon H, Kakuta M, Ishii C, Hirasawa A, Utsui Y, Ohya S, Yasuda H.
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [Abstract] [Full Text] [Related]

  • 3. [Transferability of vancomycin to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
    Haruta T, Okura K, Kuroki S, Nigami H, Kobayashi Y.
    Jpn J Antibiot; 1993 Feb; 46(2):154-8. PubMed ID: 8331775
    [Abstract] [Full Text] [Related]

  • 4. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
    Eng RH, Smith SM, Buccini FJ, Cherubin CE.
    J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS, Lam K.
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Fernández Viladrich P, Gudiol F.
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [Abstract] [Full Text] [Related]

  • 7. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM, Keeley JM, Field MR, Brodeur JP.
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases.
    Gombert ME, Landesman SH, Corrado ML, Stein SC, Melvin ET, Cummings M.
    J Neurosurg; 1981 Oct; 55(4):633-6. PubMed ID: 7277012
    [Abstract] [Full Text] [Related]

  • 9. Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Leonard SN.
    PLoS One; 2012 Oct; 7(7):e42103. PubMed ID: 22848719
    [Abstract] [Full Text] [Related]

  • 10. MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim.
    Fujino T, Amari Y, Mohri M, Noma M, Yamamoto H.
    J Cardiol; 2009 Feb; 53(1):146-9. PubMed ID: 19167651
    [Abstract] [Full Text] [Related]

  • 11. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW.
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [Abstract] [Full Text] [Related]

  • 12. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M, Asari S, Nishi I, Horikawa M, Tsukamoto H, Sunada A, Ueda A, Iwatani Y.
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY, Lazzarini L, Li F, Stevens CM, Calhoun JH.
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.
    BMC Infect Dis; 2011 Oct 19; 11():279. PubMed ID: 22011388
    [Abstract] [Full Text] [Related]

  • 15. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD, Wexler MA, Steigbigel NH.
    J Lab Clin Med; 1982 Jul 19; 100(1):94-104. PubMed ID: 6919570
    [Abstract] [Full Text] [Related]

  • 16. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL.
    Pediatr Infect Dis J; 2003 Jul 19; 22(7):593-8. PubMed ID: 12867833
    [Abstract] [Full Text] [Related]

  • 17. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
    Norden CW, Shaffer M.
    J Infect Dis; 1983 Feb 19; 147(2):352-7. PubMed ID: 6827150
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
    Salem AH, Elkhatib WF, Noreddin AM.
    J Pharm Pharmacol; 2011 Jan 19; 63(1):73-9. PubMed ID: 21155818
    [Abstract] [Full Text] [Related]

  • 19. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
    Henry NK, Rouse MS, Whitesell AL, McConnell ME, Wilson WR.
    Am J Med; 1987 Apr 27; 82(4A):73-5. PubMed ID: 3578332
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May 27; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.